3-(2,2-Dimethyl-1,3-benzodioxol-5-yl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine(CAS: 852288-18-7)

This compound falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes labeling requirements for flammability, reactivity, and health hazards. Additionally, it is subject to REACH regulations in the European Union for registration, evaluation, authorization, and restriction of chemicals. FDA and EPA have specific guidelines for the handling and disposal of this compound, which may be used in pharmaceutical and research applications.

Several alternatives can be used in the synthesis of this compound, including other L-amino acids and various fluorenylmethoxycarbonyl (Fmoc) protecting groups. Analogous compounds with similar structures, such as 3-(2,2-dimethyl-1,3-benzodioxol-5-yl)-L-alanine, may also serve as viable substitutes, depending on the specific application and desired properties.

The market for this compound is primarily driven by its use in medicinal chemistry and pharmaceutical research, particularly in drug discovery and development. Recent research trends indicate a growing interest in its potential as an intermediate in the synthesis of bioactive molecules, with a focus on optimizing its properties for improved efficacy and reduced toxicity. Market demand is expected to increase as new applications are discovered and optimized.

Waste containing this compound should be collected in appropriate, labeled containers and disposed of according to local regulations. Incineration is a common method for disposal, but professional waste disposal services may be required. Environmental protection measures should include proper containment to prevent spillage and ensure the waste is safely transported to a licensed facility. Compliance with GHS and REACH guidelines is essential throughout the handling and disposal process.